About

Mr. Pamir is the Chief Financial Officer at ChromaDex. Prior to joining ChromaDex, Ozan Pamir most recently served as Chief Financial Officer of 180 Life Sciences, a NASDAQ-traded biotechnology company focused on the treatment of inflammatory diseases. He played a key role in completing the company’s NASDAQ listing and managed the majority of funding rounds. In addition to 180 Life Sciences, Mr. Pamir worked with two early-stage biotech companies as Chief Financial Officer and board member.

Previously, Mr. Pamir was VP of Investment Banking at a leading independent investment bank, where he co-founded the Origination department and specialized in helping small and mid-cap life sciences companies define their corporate strategy and executive financing and advisory mandates.
Mr. Pamir holds an Economics and Finance degree from McGill University and is a CFA Charterholder.